Medical comms - Press Releases

Date	Title	Company
17-Jun-2020	Evelo Biosciences to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference	Evelo Biosciences
17-Jun-2020	New Data from Phase 3 Studies Support Maintained Transfusion Independence* for Patients Across Genotypes Treated with betibeglogene autotemcel (LentiGlobin for β-thalassaemia) Gene Therapy	bluebird bio
17-Jun-2020	FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients	The U.S. Food and Drug Administration
17-Jun-2020	Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease	Sanofi
17-Jun-2020	Sanofi invests to make France its world class center of excellence in vaccine research and production	Sanofi
17-Jun-2020	Investigational, once-weekly insulin icodec showed comparable efficacy and safety to once-daily insulin glargine U100 in phase 2 trial	Novo Nordisk
17-Jun-2020	Santhera Completes Capital Increase for Financing Arrangements	Santhera Pharmaceuticals
17-Jun-2020	Diaverum continues to grow its international presence by acquiring the CTN clinic in São Paulo, Brazil	Diaverum
17-Jun-2020	FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients	Thermo Fisher Scientific
17-Jun-2020	Gloucestershire Hospitals NHS Trust quickly responds to COVID-19 with Citrix	Gloucestershire Hospitals NHS Trust
17-Jun-2020	Celltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kits	Celltrion Healthcare
17-Jun-2020	Kancera's drug candidate KAND567 has a positive effect on mobility in a preclinical model of spinal cord injury	Kancera AB
17-Jun-2020	ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron	ISA Pharmaceuticals
17-Jun-2020	Regulatory approvals and programme update	ReNeuron Group plc
17-Jun-2020	Call for pharmacists to receive formal training in suicide and self-harm	The University of Huddersfield
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics, Inc
17-Jun-2020	ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV	ViiV Healthcare
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics
12-Jun-2020	AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020	AstraZeneca
12-Jun-2020	AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress	AstraZeneca